|
Age, years
|
67.8 ± 10.2
|
67.6 ± 11.6
|
0.919
|
|
Male, %
|
60.8
|
52.8
|
0.413
|
|
Body mass index, kg/m2
|
21.9 ± 3.6
|
21.8 ± 3.2
|
0.815
|
|
Hemodialysis vintage, months
|
94.7 ± 89.0
|
108.0 ± 75.5
|
0.158
|
|
Single-pool Kt/V
|
1.05 ± 0.20
|
1.12 ± 0.24
|
0.113
|
|
Mean CERA dose, μg/4 weeks
|
129.6 ± 66.9
|
117.9 ± 68.2
|
0.344
|
|
Arteriovenous fistula, %
|
96.1
|
98.1
|
0.465
|
|
Renin-angiotensin system inhibitors, %
|
49.0
|
58.5
|
0.333
|
|
Diabetes mellitus, %
|
35.3
|
41.5
|
0.515
|
|
Hypertension, %
|
96.1
|
98.1
|
0.485
|
|
Cardio vascular disease, %
|
25.5
|
24.5
|
0.910
|
|
Hematologic disease, %
|
5.9
|
1.9
|
0.294
|
|
Hemoglobin, g/dl
|
10.7 ± 0.7
|
10.8 ± 0.9
|
0.767
|
|
Creatinin, mg/dl
|
11.0 ± 2.2
|
1.0 ± 2.5
|
0.906
|
|
Blood urea nitrogen, mg/dl
|
71.6 ± 17.1
|
72.3 ± 14.6
|
0.844
|
|
Albumin, g/dl
|
3.85 ± 0.22
|
3.85 ± 0.31
|
0.969
|
|
C-reactive protein, mg/dl
|
0.32 ± 0.54
|
0.22 ± 0.34
|
0.865
|
|
Intact-parathyroid hormon, pg/ml
|
164.7 ± 78.8
|
180.1 ± 108.2
|
0.797
|
|
Serum iron, μg/dl
|
96.4 ± 30.1
|
89.6 ± 25.9
|
0.248
|
|
Total Iron binding capacity, μg/dl
|
236.7 ± 34.1
|
237.1 ± 42.7
|
0.955
|
|
Transferrin saturation, %
|
40.9 ± 14.2
|
40.2 ± 14.8
|
0.826
|
|
Ferritin, ng/ml
|
163.3 ± 63.7
|
169.6 ± 63.1
|
0.623
|
